Patents by Inventor Vyjayanthi Krishnan

Vyjayanthi Krishnan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Therapeutic Regimens and Methods for Lowering Blood Glucose and/or Body Weight using GLP-1R and GCGR Balanced Agonists
    Publication number: 20250134963
    Abstract: This disclosure relates to the once weekly dosing regimen of a dual GLP-1R and GCGR agonist, formulations, and methods of using the same for treatment of chronic weight management, obesity and/or blood glucose control, including but not limited to dual agonist peptide product of SEQ ID NO. 1.
    Type: Application
    Filed: November 11, 2024
    Publication date: May 1, 2025
    Applicant: Spitfire Pharma LLC
    Inventors: Vyjayanthi Krishnan, Joyce James, Omar Roble Olhaye, Matthew Scott Harris
  • Therapeutic regimens and methods for lowering blood glucose and/or body weight using GLP-1R and GCGR balanced agonists
    Patent number: 12171806
    Abstract: This disclosure relates to the once weekly dosing regimen of a dual GLP-1R and GCGR agonist, formulations, and methods of using the same for treatment of chronic weight management, obesity and/or blood glucose control, including but not limited to dual agonist peptide product of SEQ ID NO. 1.
    Type: Grant
    Filed: December 7, 2021
    Date of Patent: December 24, 2024
    Assignee: Spitfire Pharma LLC
    Inventors: Vyjayanthi Krishnan, Joyce James, Omar Roble Olhaye, Matthew Scott Harris
  • Therapeutic Regimens and Methods for Lowering Blood Glucose and/or Body Weight using GLP-1R and GCGR Balanced Agonists
    Publication number: 20230104501
    Abstract: This disclosure relates to the once weekly dosing regimen of a dual GLP-1R and GCGR agonist, formulations, and methods of using the same for treatment of chronic weight management, obesity and/or blood glucose control, including but not limited to dual agonist peptide product of SEQ ID NO. 1.
    Type: Application
    Filed: December 7, 2021
    Publication date: April 6, 2023
    Applicant: Spitfire Pharma LLC
    Inventors: Vyjayanthi Krishnan, Joyce James, Omar Roble Olhaye, Matthew Scott Harris
  • Therapeutic Agent Effectiveness and its Route of Adminstration
    Publication number: 20220354943
    Abstract: Disclosed herein are methods for generating a protective immunogenic response via intranasal administration of an immunogenic composition (e.g., vaccine)/therapeutic immunogenic composition in a mammalian subject. Certain dosing positions of the subject during the administration of immunogenic agents, such that nostrils are tilted upwards, while in a modified sitting, reclining and/or supine posture, is surprisingly correlated with the generation of a strong immunogenic response in both humans and animals.
    Type: Application
    Filed: August 13, 2020
    Publication date: November 10, 2022
    Applicant: Altimmune, Inc
    Inventors: Vyjayanthi Krishnan, M. Scot Roberts
  • GLP-1R and GCGR Agonists, Formulations, and Methods of Use
    Publication number: 20210290732
    Abstract: This disclosure relates to the field of GLP-1R and GCGR agonists, formulations, and methods of using the same, including but not limited to dual agonist peptides of any of SEQ ID NOS. 1-10 or 12-27 conjugated to a non-ionic glycolipid surfactant.
    Type: Application
    Filed: February 21, 2021
    Publication date: September 23, 2021
    Applicant: Spitfire Pharma LLC
    Inventors: John J Nestor, Vyjayanthi Krishnan